KP Tissue - KPT Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for KP Tissue in the last year. There are currently 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" KPT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KPT, but not buy additional shares or sell existing shares.
View KPT analyst ratings or view top-rated stocks.

3 brokers have issued twelve-month price targets for KP Tissue's stock. Their KPT share price forecasts range from C$10.00 to C$11.00. On average, they expect the company's share price to reach C$10.30 in the next year. This suggests a possible upside of 1.3% from the stock's current price.
View analysts price targets for KPT or view top-rated stocks among Wall Street analysts.

KP Tissue's stock was trading at C$10.14 at the start of the year. Since then, KPT shares have increased by 0.3% and is now trading at C$10.17.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 11th 2023.
View our KPT earnings forecast.

KP Tissue announced a quarterly dividend on Thursday, March 9th. Stockholders of record on Saturday, April 1st will be paid a dividend of 0.18 per share on Monday, April 17th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 7.08%. The ex-dividend date of this dividend is Thursday, March 30th.
Read our dividend analysis for KPT.

KP Tissue (TSE:KPT) pays an annual dividend of C$0.72 per share and currently has a dividend yield of 6.99%. KPT has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for KPT.

Based on aggregate information from My MarketBeat watchlists, some companies that other KP Tissue investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Wheaton Precious Metals (WPM), Open Text (OTEX), Rogers Communications (RCI) and Valeant Pharmaceuticals International (VRX).

KP Tissue trades on the Toronto Stock Exchange (TSX) under the ticker symbol "KPT."

Shares of KPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

One share of KPT stock can currently be purchased for approximately C$10.17.

KP Tissue (TSE:KPT) has a market capitalization of C$101.19 million. The company earns C$-10,250,000.00 in net income (profit) each year or C($1.04) on an earnings per share basis.

KP Tissue's mailing address is 1900 Minnesota Crt Suite 200, MISSISSAUGA, ON L5N 5R5, Canada. The official website for the company is kptissueinc.com. The company can be reached via phone at +1-905-8126900.